Fund Overview of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw
-
₹6,293.1 CrAUM
-
₹26.03NAV
-
2.02%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 6.81% | NA | 6.12% |
| 6 Months | -1.15% | NA | 12.92% |
| 1 Year | 8.05% | 8.05% | 6.04% |
| 2 Years | 31.30% | 14.59% | 24.93% |
| 3 Years | 111.18% | 28.30% | 25.71% |
| 5 Years | 121.78% | 17.27% | 19.91% |
| 7 Years | 312.64% | 22.44% | NA |
Dividends are declared by the fund house based on the income generated from the underlying assets. While many mutual funds distribute dividends annually, the payout frequency ultimately depends on the fund house’s decision
Asset Allocation
equities
97.62%debt instruments
0.03%other assets or cash equivalents
2.35%ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw is one Equity mutual fund offered by ICICI Prudential Mutual Fund. Launched on 13 Jul 2018, the fund aims Long term wealth creation. An equity Scheme that predominantly invests in pharma, healthcare, hospitals, diagnostics, wellness and allied companies. It manages assets worth ₹6,293.1 crore as on Tue Mar 31, 2026. The expense ratio stands at 2.02%. Fund Manager Manager Education Fund Manager Manager EducationAbout ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw
The portfolio allocation consists of 97.62% in equities, 0.03% in debt instruments, 2.35% in other assets or cash equivalents.Managed by Dharmesh Kakkad, it has delivered a return of 8.05% in the last year, a total return since inception of 20.62%.
The latest dividend was declared on 07 Aug 2025 at 20.50% of face value.
Identifying a suitable which sip is best plays a key part in financial planning.
Key Metrics of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw
-
Standard Deviation16.39%
-
Sharpe Ratio1.15%
-
Alpha2.05%
-
Beta0.95%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | 6.92% | 6.81% | 8.05% | 28.30% | 17.27% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | 6.92% | 6.81% | 8.05% | 28.30% | 17.27% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | 2.35% | 6.02% | 1.50% | 25.34% | 16.38% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹4,064 | 2.35% | 6.02% | 1.50% | 25.34% | 16.38% |
| Mirae Asset Healthcare Fund Direct-growth |
₹2,754 | 5.23% | 11.59% | 12.13% | 26.23% | 16.38% |
| Mirae Asset Healthcare Fund Direct-idcw |
₹2,754 | 5.23% | 11.59% | 12.13% | 26.23% | 16.38% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | 6.85% | 6.60% | 7.16% | 27.21% | 16.24% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | 6.85% | 6.60% | 7.16% | 27.21% | 16.24% |
| UTI Healthcare Fund Direct-growth |
₹1,056 | 6.27% | 8.90% | 9.88% | 26.44% | 15.34% |
| UTI Healthcare Fund Direct-idcw |
₹1,056 | 6.27% | 8.90% | 9.88% | 26.44% | 15.34% |
More funds from ICICI Prudential Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth
|
₹6,293 | 6.85% | 6.60% | -1.56% | 7.16% | 27.21% |
|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth
|
₹6,293 | 6.92% | 6.81% | -1.15% | 8.05% | 28.30% |
|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw
|
₹6,293 | 6.85% | 6.60% | -1.56% | 7.16% | 27.21% |
|
ICICI Prudential Nifty Healthcare Etf-growth
|
₹157 | 3.37% | 7.12% | 0.52% | 8.36% | 24.03% |
|
ICICI Prudential Nifty Pharma Index Fund-growth
|
₹105 | 2.59% | 6.27% | 3.52% | 7.38% | 21.79% |
|
ICICI Prudential Nifty Pharma Index Fund Direct-growth
|
₹105 | 2.65% | 6.44% | 3.85% | 8.05% | 22.55% |
|
ICICI Prudential Nifty Pharma Index Fund-idcw
|
₹105 | 2.59% | 6.27% | 3.52% | 7.38% | 21.79% |
|
ICICI Prudential Nifty Pharma Index Fund Direct-idcw
|
₹105 | 2.65% | 6.44% | 3.85% | 8.05% | 22.55% |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹7,898 | ₹517.71 | 22.49% | 13.74% | 14.44% |
| Nippon India Pharma Fund Direct-growth |
₹7,898 | ₹580.66 | 23.59% | 14.77% | 15.46% |
| Nippon India Pharma Fund-idcw |
₹7,898 | ₹111.80 | 22.49% | 13.74% | 14.44% |
| Nippon India Pharma Fund Direct-idcw |
₹7,898 | ₹158.92 | 23.59% | 14.77% | 15.46% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | ₹39.76 | 27.21% | 16.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | ₹43.11 | 28.30% | 17.27% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | ₹23.19 | 27.21% | 16.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | ₹26.03 | 28.30% | 17.27% | - |
| SBI Healthcare Opportunities Fund-growth |
₹4,064 | ₹426.36 | 24.04% | 15.16% | 11.90% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | ₹492.05 | 25.34% | 16.38% | 13.14% |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.83% | ₹828.54 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.05% | ₹777.92 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.88% | ₹764.80 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.88% | ₹764.80 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.21% | ₹762.45 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.11% | ₹762.29 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.20% | ₹745.57 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.71% | ₹721.28 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.58% | ₹721.19 Cr |
| Cipla Ltd | Healthcare | 9.40% | ₹639.45 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 9.81% | ₹634.02 Cr |
| Cipla Ltd | Healthcare | 9.43% | ₹627.97 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 9.42% | ₹606.54 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 9.42% | ₹606.54 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 9.47% | ₹583.81 Cr |
| Cipla Ltd | Healthcare | 9.23% | ₹580.64 Cr |
| Divi's Laboratories Ltd | Healthcare | 9.23% | ₹568.96 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 9.10% | ₹566.95 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.50% | ₹547.49 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.50% | ₹547.49 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.75% | ₹544.91 Cr |
| Mankind Pharma Ltd. | Healthcare | 7.64% | ₹519.83 Cr |
| Cipla Ltd | Healthcare | 8.00% | ₹516.67 Cr |
| Aurobindo Pharma Ltd | Healthcare | 8.25% | ₹513.73 Cr |
| Cipla Ltd | Healthcare | 7.90% | ₹509.92 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.82% | ₹505.14 Cr |
| Aurobindo Pharma Ltd | Healthcare | 7.62% | ₹490.41 Cr |
| Aurobindo Pharma Ltd | Healthcare | 7.62% | ₹490.41 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.27% | ₹483.96 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.48% | ₹482.98 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.10% | ₹458.33 Cr |
| Cipla Ltd | Healthcare | 7.39% | ₹455.62 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 6.52% | ₹443.63 Cr |
| Mankind Pharma Ltd. | Healthcare | 7.01% | ₹441.43 Cr |
| Cipla Ltd | Healthcare | 6.92% | ₹430.94 Cr |
| Cipla Ltd | Healthcare | 6.61% | ₹425.53 Cr |
| Cipla Ltd | Healthcare | 6.61% | ₹425.53 Cr |
| Mankind Pharma Ltd. | Healthcare | 6.34% | ₹421.98 Cr |
| Biocon Ltd | Healthcare | 6.20% | ₹421.91 Cr |
| Mankind Pharma Ltd. | Healthcare | 6.44% | ₹415.63 Cr |
| Divi's Laboratories Ltd | Healthcare | 6.22% | ₹414.30 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.95% | ₹404.34 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.53% | ₹402.19 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.04% | ₹390.15 Cr |
| Biocon Ltd | Healthcare | 5.85% | ₹389.71 Cr |
| Biocon Ltd | Healthcare | 6.08% | ₹382.43 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.97% | ₹375.89 Cr |
| Lupin Ltd | Healthcare | 5.78% | ₹373.31 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.91% | ₹371.62 Cr |
| Lupin Ltd | Healthcare | 5.70% | ₹368.47 Cr |
| Lupin Ltd | Healthcare | 5.40% | ₹347.47 Cr |
| Lupin Ltd | Healthcare | 5.40% | ₹347.47 Cr |
| Lupin Ltd | Healthcare | 5.43% | ₹338.23 Cr |
| Lupin Ltd | Healthcare | 5.44% | ₹335.33 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.19% | ₹335.21 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.04% | ₹325.27 Cr |
| Lupin Ltd | Healthcare | 4.80% | ₹319.57 Cr |
| Lupin Ltd | Healthcare | 3.99% | ₹271.04 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.91% | ₹260.34 Cr |
| Lupin Ltd | Healthcare | 4.09% | ₹257.18 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.98% | ₹256.14 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.98% | ₹256.14 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.05% | ₹252.35 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.70% | ₹251.39 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.00% | ₹246.70 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.78% | ₹244.06 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.66% | ₹236.40 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.47% | ₹235.88 Cr |
| Repo | Unspecified | 3.63% | ₹223.45 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.52% | ₹221.82 Cr |
| Syngene International Ltd | Healthcare | 3.52% | ₹221.35 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.50% | ₹215.75 Cr |
| Syngene International Ltd | Healthcare | 3.16% | ₹215.17 Cr |
| Biocon Ltd | Healthcare | 3.28% | ₹211.36 Cr |
| Biocon Ltd | Healthcare | 3.28% | ₹211.36 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.30% | ₹207.73 Cr |
| Repo | Unspecified | 3.18% | ₹204.95 Cr |
| Repo | Unspecified | 3.18% | ₹204.95 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 3.18% | ₹199.85 Cr |
| Syngene International Ltd | Healthcare | 2.99% | ₹199.11 Cr |
| Biocon Ltd | Healthcare | 3.21% | ₹197.87 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 3.01% | ₹194.11 Cr |
| Biocon Ltd | Healthcare | 3.11% | ₹193.70 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.90% | ₹193.01 Cr |
| Syngene International Ltd | Healthcare | 2.98% | ₹192.44 Cr |
| Syngene International Ltd | Healthcare | 2.97% | ₹191.65 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.77% | ₹188.49 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.80% | ₹186.43 Cr |
| Gland Pharma Ltd | Healthcare | 2.97% | ₹184.82 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.95% | ₹183.41 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.79% | ₹179.51 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.79% | ₹179.51 Cr |
| Gland Pharma Ltd | Healthcare | 2.88% | ₹177.28 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.68% | ₹173.16 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.78% | ₹172.94 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.80% | ₹172.79 Cr |
| Medplus Health Services Ltd | Healthcare | 2.54% | ₹172.47 Cr |
| Medplus Health Services Ltd | Healthcare | 2.73% | ₹171.79 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.67% | ₹171.62 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.67% | ₹171.62 Cr |
| Repo | Unspecified | 2.68% | ₹168.47 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.57% | ₹166.00 Cr |
| Repo | Unspecified | 2.48% | ₹164.84 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.49% | ₹161.04 Cr |
| Repo | Unspecified | 2.58% | ₹160.51 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.34% | ₹155.92 Cr |
| Glenmark Life Sciences Ltd | Healthcare | 2.44% | ₹153.37 Cr |
| Glenmark Life Sciences Ltd | Healthcare | 2.28% | ₹151.53 Cr |
| Repo | Unspecified | 2.18% | ₹148.20 Cr |
| Glenmark Life Sciences Ltd | Healthcare | 2.24% | ₹144.51 Cr |
| Glenmark Life Sciences Ltd | Healthcare | 2.11% | ₹143.76 Cr |
| Repo | Unspecified | 2.23% | ₹143.75 Cr |
| Syngene International Ltd | Healthcare | 2.23% | ₹143.42 Cr |
| Syngene International Ltd | Healthcare | 2.23% | ₹143.42 Cr |
| Biocon Ltd | Healthcare | 2.20% | ₹142.14 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.07% | ₹140.91 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.15% | ₹139.02 Cr |
| Syngene International Ltd | Healthcare | 2.21% | ₹137.41 Cr |
| Repo | Unspecified | 2.09% | ₹134.90 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.08% | ₹134.20 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.08% | ₹134.20 Cr |
| Syngene International Ltd | Healthcare | 2.18% | ₹134.08 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.03% | ₹130.62 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.03% | ₹130.62 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.03% | ₹127.71 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.94% | ₹125.00 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.91% | ₹123.26 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.91% | ₹123.26 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.89% | ₹122.13 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 1.77% | ₹120.43 Cr |
| Entero Healthcare Solutions Ltd. | Healthcare | 1.90% | ₹119.57 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.90% | ₹119.47 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.85% | ₹119.41 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.79% | ₹119.29 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.75% | ₹118.84 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.75% | ₹118.70 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.77% | ₹117.79 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 1.83% | ₹114.99 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.77% | ₹113.91 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.77% | ₹113.91 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.81% | ₹112.88 Cr |
| Gland Pharma Ltd | Healthcare | 1.72% | ₹110.91 Cr |
| Gland Pharma Ltd | Healthcare | 1.72% | ₹110.91 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 1.71% | ₹110.63 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.71% | ₹110.62 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.78% | ₹109.50 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.74% | ₹109.22 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.60% | ₹108.88 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 1.63% | ₹108.44 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.62% | ₹108.19 Cr |
| Entero Healthcare Solutions Ltd. | Healthcare | 1.60% | ₹106.23 Cr |
| Gland Pharma Ltd | Healthcare | 1.59% | ₹106.16 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.70% | ₹106.15 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.63% | ₹105.31 Cr |
| Gland Pharma Ltd | Healthcare | 1.54% | ₹104.76 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.59% | ₹102.82 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.59% | ₹102.51 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.64% | ₹102.33 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.62% | ₹102.23 Cr |
| Gland Pharma Ltd | Healthcare | 1.57% | ₹101.16 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.63% | ₹100.67 Cr |
| Entero Healthcare Solutions Ltd. | Healthcare | 1.46% | ₹99.22 Cr |
| Gland Pharma Ltd | Healthcare | 1.53% | ₹99.00 Cr |
| Entero Healthcare Solutions Ltd. | Healthcare | 1.53% | ₹98.70 Cr |
| Gland Pharma Ltd | Healthcare | 1.55% | ₹97.51 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.51% | ₹97.36 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.51% | ₹97.36 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.57% | ₹96.70 Cr |
| Medplus Health Services Ltd | Healthcare | 1.45% | ₹96.37 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.44% | ₹96.02 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.53% | ₹94.58 Cr |
| Pfizer Ltd | Healthcare | 1.46% | ₹94.27 Cr |
| Pfizer Ltd | Healthcare | 1.46% | ₹94.27 Cr |
| Pfizer Ltd | Healthcare | 1.51% | ₹93.31 Cr |
| Pfizer Ltd | Healthcare | 1.34% | ₹91.34 Cr |
| Pfizer Ltd | Healthcare | 1.46% | ₹91.14 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.41% | ₹90.96 Cr |
| Pfizer Ltd | Healthcare | 1.40% | ₹90.26 Cr |
| Pfizer Ltd | Healthcare | 1.39% | ₹90.03 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.31% | ₹89.25 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.43% | ₹89.21 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.39% | ₹86.75 Cr |
| Medplus Health Services Ltd | Healthcare | 1.34% | ₹86.63 Cr |
| Medplus Health Services Ltd | Healthcare | 1.34% | ₹86.47 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.34% | ₹86.33 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.34% | ₹86.33 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.40% | ₹86.11 Cr |
| Windlas Biotech Ltd | Healthcare | 1.39% | ₹85.63 Cr |
| Pfizer Ltd | Healthcare | 1.35% | ₹85.17 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.32% | ₹84.97 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.31% | ₹84.61 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.31% | ₹84.52 Cr |
| Sagility India Ltd. | Industrials | 1.36% | ₹83.59 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.22% | ₹82.81 Cr |
| Pfizer Ltd | Healthcare | 1.24% | ₹82.59 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.21% | ₹82.29 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.23% | ₹82.07 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.32% | ₹81.51 Cr |
| Sagility India Ltd. | Industrials | 1.31% | ₹81.29 Cr |
| Windlas Biotech Ltd | Healthcare | 1.26% | ₹81.09 Cr |
| Windlas Biotech Ltd | Healthcare | 1.26% | ₹81.09 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.19% | ₹80.94 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.29% | ₹80.13 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.26% | ₹79.47 Cr |
| Fine Organic Industries Ltd | Materials | 1.17% | ₹79.45 Cr |
| Medplus Health Services Ltd | Healthcare | 1.23% | ₹79.11 Cr |
| Medplus Health Services Ltd | Healthcare | 1.23% | ₹79.11 Cr |
| Medplus Health Services Ltd | Healthcare | 1.28% | ₹78.90 Cr |
| Hikal Ltd | Healthcare | 1.15% | ₹78.46 Cr |
| Windlas Biotech Ltd | Healthcare | 1.25% | ₹77.69 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.16% | ₹77.24 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.19% | ₹77.10 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.15% | ₹76.37 Cr |
| Hikal Ltd | Healthcare | 1.15% | ₹76.28 Cr |
| Fine Organic Industries Ltd | Materials | 1.17% | ₹75.61 Cr |
| Fine Organic Industries Ltd | Materials | 1.17% | ₹75.61 Cr |
| Fine Organic Industries Ltd | Materials | 1.17% | ₹75.29 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.17% | ₹75.12 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.17% | ₹75.12 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.16% | ₹74.75 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.16% | ₹74.75 Cr |
| Aarti Drugs Ltd | Healthcare | 1.19% | ₹73.99 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.19% | ₹73.97 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.09% | ₹73.82 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.14% | ₹73.73 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.14% | ₹73.63 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.14% | ₹73.63 Cr |
| Aarti Drugs Ltd | Healthcare | 1.14% | ₹73.09 Cr |
| Aarti Drugs Ltd | Healthcare | 1.14% | ₹73.09 Cr |
| Hikal Ltd | Healthcare | 1.13% | ₹72.95 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.18% | ₹72.88 Cr |
| Windlas Biotech Ltd | Healthcare | 1.09% | ₹72.81 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.12% | ₹72.58 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.17% | ₹72.54 Cr |
| Aarti Drugs Ltd | Healthcare | 1.18% | ₹72.44 Cr |
| Fine Organic Industries Ltd | Materials | 1.09% | ₹72.31 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.11% | ₹71.64 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.11% | ₹71.64 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.14% | ₹71.45 Cr |
| Medplus Health Services Ltd | Healthcare | 1.14% | ₹70.98 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.13% | ₹70.90 Cr |
| Aarti Drugs Ltd | Healthcare | 1.10% | ₹70.88 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.14% | ₹70.69 Cr |
| Fine Organic Industries Ltd | Materials | 1.14% | ₹70.52 Cr |
| Fine Organic Industries Ltd | Materials | 1.09% | ₹70.14 Cr |
| Aarti Drugs Ltd | Healthcare | 1.04% | ₹69.51 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.12% | ₹68.97 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.06% | ₹68.58 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.10% | ₹68.39 Cr |
| Windlas Biotech Ltd | Healthcare | 1.06% | ₹68.19 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.06% | ₹67.97 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.06% | ₹67.97 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.10% | ₹67.90 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.09% | ₹67.88 Cr |
| Fine Organic Industries Ltd | Materials | 1.08% | ₹67.35 Cr |
| Windlas Biotech Ltd | Healthcare | 1.04% | ₹67.21 Cr |
| Aarti Drugs Ltd | Healthcare | 0.98% | ₹66.95 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.06% | ₹66.93 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.03% | ₹66.81 Cr |
| Fine Organic Industries Ltd | Materials | 1.06% | ₹66.74 Cr |
| Shilpa Medicare Ltd | Healthcare | 0.97% | ₹65.97 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.02% | ₹65.78 Cr |
| Windlas Biotech Ltd | Healthcare | 0.95% | ₹64.75 Cr |
| Windlas Biotech Ltd | Healthcare | 1.00% | ₹63.19 Cr |
| Anthem Biosciences Ltd. | Healthcare | 0.95% | ₹63.08 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.01% | ₹62.10 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.98% | ₹61.88 Cr |
| Shilpa Medicare Ltd | Healthcare | 0.96% | ₹61.86 Cr |
| Aarti Drugs Ltd | Healthcare | 0.96% | ₹61.75 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.88% | ₹59.94 Cr |
| Hikal Ltd | Healthcare | 0.92% | ₹59.12 Cr |
| Hikal Ltd | Healthcare | 0.93% | ₹58.83 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.91% | ₹58.78 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.91% | ₹58.78 Cr |
| Aarti Drugs Ltd | Healthcare | 0.93% | ₹58.68 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.92% | ₹57.05 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.85% | ₹56.71 Cr |
| Shilpa Medicare Ltd | Healthcare | 0.85% | ₹56.62 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.86% | ₹55.62 Cr |
| Fdc Ltd | Healthcare | 0.86% | ₹55.17 Cr |
| Fdc Ltd | Healthcare | 0.86% | ₹55.17 Cr |
| Fdc Ltd | Healthcare | 0.89% | ₹54.82 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.89% | ₹54.80 Cr |
| Hikal Ltd | Healthcare | 0.84% | ₹54.22 Cr |
| Hikal Ltd | Healthcare | 0.84% | ₹54.22 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.84% | ₹54.17 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.83% | ₹53.90 Cr |
| Fdc Ltd | Healthcare | 0.85% | ₹52.97 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.82% | ₹52.79 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.82% | ₹52.69 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.82% | ₹52.57 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.82% | ₹52.57 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.84% | ₹52.28 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.76% | ₹51.57 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.79% | ₹51.17 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.79% | ₹51.17 Cr |
| Fdc Ltd | Healthcare | 0.78% | ₹50.67 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.78% | ₹50.51 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.78% | ₹50.51 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.76% | ₹50.50 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.80% | ₹50.10 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.80% | ₹49.88 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.75% | ₹49.83 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.81% | ₹49.69 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.77% | ₹49.68 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.77% | ₹49.65 Cr |
| Fdc Ltd | Healthcare | 0.77% | ₹49.63 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 0.79% | ₹49.56 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.77% | ₹49.42 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.77% | ₹49.42 Cr |
| Rubicon Research Ltd. | 0.74% | ₹49.38 Cr | |
| Rubicon Research Ltd. | 0.76% | ₹49.13 Cr | |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.71% | ₹48.39 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.76% | ₹48.06 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.77% | ₹47.78 Cr |
| Shilpa Medicare Ltd | Healthcare | 0.75% | ₹47.43 Cr |
| Rubicon Research Ltd. | 0.73% | ₹47.33 Cr | |
| Astrazeneca Pharma India Ltd | Healthcare | 0.76% | ₹46.55 Cr |
| Yatharth Hospital & Trauma Care Services Ltd. | Healthcare | 0.75% | ₹45.99 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.71% | ₹45.84 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.72% | ₹45.26 Cr |
| Fdc Ltd | Healthcare | 0.68% | ₹45.24 Cr |
| Rubicon Research Ltd. | 0.69% | ₹44.61 Cr | |
| Rubicon Research Ltd. | 0.69% | ₹44.61 Cr | |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.72% | ₹44.23 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.71% | ₹44.10 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.68% | ₹44.07 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.68% | ₹44.07 Cr |
| Fdc Ltd | Healthcare | 0.63% | ₹42.72 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.63% | ₹42.52 Cr |
| Sagility India Ltd. | Industrials | 0.66% | ₹42.22 Cr |
| Sagility India Ltd. | Industrials | 0.66% | ₹42.22 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.63% | ₹41.73 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.63% | ₹40.90 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.63% | ₹40.76 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.63% | ₹40.50 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.63% | ₹40.50 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.62% | ₹40.29 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.63% | ₹39.10 Cr |
| Fdc Ltd | Healthcare | 0.62% | ₹38.88 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.61% | ₹38.29 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.56% | ₹34.94 Cr |
| Nephrocare Health Services Ltd. | 0.48% | ₹32.65 Cr | |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.45% | ₹30.67 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.46% | ₹30.43 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.48% | ₹29.94 Cr |
| Nephrocare Health Services Ltd. | 0.44% | ₹29.02 Cr | |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.44% | ₹28.68 Cr |
| Nephrocare Health Services Ltd. | 0.44% | ₹27.87 Cr | |
| Hikal Ltd | Healthcare | 0.44% | ₹27.60 Cr |
| Nephrocare Health Services Ltd. | 0.39% | ₹25.47 Cr | |
| Net Current Assets | Unspecified | 0.36% | ₹21.91 Cr |
| Advanced Enzyme Technologies Ltd | Materials | 0.29% | ₹18.05 Cr |
| Hikal Ltd | Healthcare | 0.29% | ₹17.85 Cr |
| Rubicon Research Ltd. | 0.26% | ₹17.72 Cr | |
| Yatharth Hospital & Trauma Care Services Ltd. | Healthcare | 0.24% | ₹15.05 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.13% | ₹8.90 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.13% | ₹8.68 Cr |
| Cash Margin | Unspecified | 0.14% | ₹8.41 Cr |
| Cash Margin | Unspecified | 0.13% | ₹8.41 Cr |
| Cash Margin | Unspecified | 0.13% | ₹8.41 Cr |
| Cash Margin | Unspecified | 0.13% | ₹8.41 Cr |
| Cash Margin | Unspecified | 0.13% | ₹8.41 Cr |
| Cash Margin | Unspecified | 0.13% | ₹8.41 Cr |
| Advanced Enzyme Technologies Ltd | Materials | 0.07% | ₹4.47 Cr |
| 91 Dtb (09-apr-2026) | Financial | 0.03% | ₹2.00 Cr |
| 91 Dtb (09-apr-2026) | Financial | 0.03% | ₹1.99 Cr |
| 91 Dtb (09-apr-2026) | Financial | 0.03% | ₹1.98 Cr |
| Ipca Laboratories Ltd | Healthcare | 0.01% | ₹0.62 Cr |
| Cash Margin | Unspecified | 0.01% | ₹0.41 Cr |
| Cash Margin | Unspecified | 0.01% | ₹0.41 Cr |
| Cash Margin | Unspecified | 0.01% | ₹0.41 Cr |
| Net Payables | Unspecified | -0.06% | ₹-3.87 Cr |
| Net Payables | Unspecified | -0.09% | ₹-5.90 Cr |
| Net Payables | Unspecified | -0.11% | ₹-7.32 Cr |
| Net Payables | Unspecified | -0.19% | ₹-13.21 Cr |
| Net Payables | Unspecified | -0.26% | ₹-16.22 Cr |
| Net Payables | Unspecified | -0.33% | ₹-20.99 Cr |
| Net Payables | Unspecified | -0.41% | ₹-26.44 Cr |
| Net Payables | Unspecified | -0.41% | ₹-26.44 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹43.11 | 28.30% | 17.27% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹26.03 | 28.30% | 17.27% | - |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹492.05 | 25.34% | 16.38% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹341.86 | 25.34% | 16.38% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹45.41 | 26.23% | 16.38% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹27.35 | 26.23% | 16.38% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹39.76 | 27.21% | 16.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹23.19 | 27.21% | 16.24% | - |
| UTI Healthcare Fund Direct-growth |
₹331.99 | 26.44% | 15.34% | - |
| UTI Healthcare Fund Direct-idcw |
₹256.60 | 26.44% | 15.34% | - |
Frequently Asked Questions
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw
What is the current AUM of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw?
As of Tue Mar 31, 2026, ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw manages assets worth ₹6,293.1 crore
How has ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw performed recently?
- 3 Months: 6.81%
- 6 Months: -1.15%
What is the long-term performance of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw?
- 3 Years CAGR: 28.30%
- 5 Years CAGR: 17.27%
- Since Inception: 20.62%
What is the portfolio composition of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw?
Equity: 97.62%, Debt: 0.03%, Others: 2.35%.
Who manages ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw?
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw is managed by Dharmesh Kakkad from ICICI Prudential Mutual Fund.
When was the last dividend declared by ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw?
Latest dividend was declared on 07 Aug 2025 at 20.50% of face value.
What is the market-cap allocation of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw?
Large Cap: 34.03%, Mid Cap: 28.56%, Small Cap: 37.41%.
Which are the top companies ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw has invested in?
- Sun Pharmaceutical Industries Ltd – 12.83% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.05% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.88% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.88% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.21% of the fund's portfolio
Which are the major sectors ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw focuses on?
- Healthcare – 836.01% of the fund's portfolio
- Unspecified – 23.51% of the fund's portfolio
- Industrials – 18.59% of the fund's portfolio
- Materials – 10.51% of the fund's portfolio
- Financial – 5.74% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





